Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 07-2000 | 06-2000 | 04-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,300 | N/A | N/A | 868 | N/A |
| Depreciation Amortization | 270 | N/A | 150 | 157 | 100 |
| Accounts receivable | N/A | N/A | N/A | 670 | N/A |
| Other Working Capital | -320 | N/A | 500 | 501 | -250 |
| Other Operating Activity | -800 | 0 | -750 | -1,428 | -1 |
| Operating Cash Flow | $450 | $N/A | $-100 | $767 | $-151 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -1,456 | N/A |
| PPE Investments | -30 | N/A | -30 | -31 | -20 |
| Purchase Of Investment | N/A | N/A | N/A | -687 | N/A |
| Other Investing Activity | -960 | 0 | -2,140 | 0 | -280 |
| Investing Cash Flow | $-990 | $N/A | $-2,170 | $-2,173 | $-300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 1,578 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -277 | N/A |
| Other Financing Activity | 1,340 | 0 | 1,300 | 0 | 120 |
| Financing Cash Flow | $1,340 | $N/A | $1,300 | $1,301 | $120 |
| Beginning Cash Position | 900 | N/A | N/A | 186 | N/A |
| End Cash Position | 1,710 | N/A | N/A | 81 | N/A |
| Net Cash Flow | $800 | $N/A | $-970 | $-105 | $-331 |
| Free Cash Flow | |||||
| Operating Cash Flow | 450 | N/A | -100 | 767 | -151 |
| Capital Expenditure | N/A | N/A | N/A | -31 | N/A |
| Free Cash Flow | 450 | 0 | -100 | 736 | -151 |